<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180930041179N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-12-21</date_registration>
      <primary_sponsor>Bagheiat-allah University of Medical Sciences</primary_sponsor>
      <public_title>Effect of low level laser on nerve healing</public_title>
      <acronym></acronym>
      <scientific_title>Effect of low – level laser irradiation on healing process of lower lip hypoesthesia following sagittal split ramus osteotomy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2017-10-12</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/34173</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The patients will be divided into the groups in an individual simple random sampling (SRS) manner. In this order random number table will be used. Any of 500 referred patients to the hospital who need orthognathic surgery will have a number. These numbers will be put in the number table without any pattern and totally disorderly. The numbers are found by a second blinded person in order to allocation concealment. At first a point is selected to start. By default, the direction from left to right is set. By moving on the table each number will be recorded which is the person who is included in the study. By default, numbers under 250 are included in the intervention group and numbers over 250 are included in control group. This process will be continued until 40 patients (sample size) are completed, Blinding description: Every patient is included in control or intervention group randomly and is not informed about that.In control group the probe is used whilst the laser unit is off. In this order the patients will not understand that whether the laser is irradiated or not and are blinded to the survey. The examiner who assesses the outcomes is not aware that each patient is whether in the intervention group or not. Actually the study is designed to be double blinded.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Neurosensory disturbance in facial area.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Laser irradiation would be performed immediately, 24 hours, 48 hours, and 72 hours following surgery. Laser therapy is continued three times a week in the next two weeks (total 10 sessions).  Diode laser wavelength is 810 nm, the power density is 8.4 j/cm2, power is 70 mW, and the beam diameter is 8mm. Intervention 2: Control group: Laser irradiation would be performed immediately, 24 hours, 48 hours, and 72 hours following surgery. Laser therapy is continued three times a week in the next two weeks (total 10 sessions).probe is used whilst the laser unit is off.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information exist.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Esmaeelinejad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Dentistry, Semnan University of Medical Sciences, Hefdah Shahrivar St., Saadi square</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۳۵۱۳۱۳۸۱۱۱</zip>
        <telephone>+98 23 3332 4700</telephone>
        <email>esmaeelnejad@gmail.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Esmaeelinejad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Dentistry, Semnan University of Medical Sciences, Hefdah Shahrivar St., Saadi square</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۳۵۱۳۱۳۸۱۱۱</zip>
        <telephone>+98 23 3332 4700</telephone>
        <email>esmaeelnejad@gmail.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients who undergo sagittal split osteotomy surgery.
Nerve damage is as neuropraxia.
No technical error is occurred during surgery.
No previous facial surgery is mentioned.
No previous nerve damage is mentioned.
Patients are not medically compromised.
Patients do not consume anticonvulsants and antidepressants drugs.</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of previous orthognathic surgery
History of neurosensory disturbance in the facial area
Inappropriate surgical technique or complication occurrence
Neurotmesis or axonotmesis happening
Medically compromised patients
Uncooperative patients</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G50.8</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other disorders of trigeminal nerve</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Laser irradiation would be performed immediately, 24 hours, 48 hours, and 72 hours following surgery. Laser therapy is continued three times a week in the next two weeks (total 10 sessions).  Diode laser wavelength is 810 nm, the power density is 8.4 j/cm2, power is 70 mW, and the beam diameter is 8mm.</i_keyword>
      <i_keyword>Control group: Laser irradiation would be performed immediately, 24 hours, 48 hours, and 72 hours following surgery. Laser therapy is continued three times a week in the next two weeks (total 10 sessions).probe is used whilst the laser unit is off</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Patient’s satisfaction. Timepoint: One, three, six, and twelve months after laser therapy. Method of measurement: Visual Analogue Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pinprick test. Timepoint: One, three, six, and twelve months after laser therapy. Method of measurement: Pinprick test; is defined as the patient’s ability to identify the sharp needle touching the affected skin. Dental probe is used for this test with the constant force.</sec_outcome>
      <sec_outcome>Thermal test. Timepoint: One, three, six, and twelve months after laser therapy. Method of measurement: Thermal test; which is defined as the patient’s ability to discern either the heat or cool probe. Small glass tubes containing water at15°C and 50°C are used. The perception of either cold or hot stimulus is recorded.</sec_outcome>
      <sec_outcome>Two-point discrimination. Timepoint: One, three, six, and twelve months after laser therapy. Method of measurement: Two-point discrimination test; which is defined as the patient’s ability to detect the two nearby objects contacting the face skin truly two distinct points, not one. A calibrated drawing compass was used with minimum error (reproducibility more than 95%).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Bagheiat-allah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-10-03</approval_date>
        <contact_name>Ethics committee of Baqiatallah University of Medical Sciences</contact_name>
        <contact_address>Vice chancellor for research, Baqiyatallah university, Sheikhbahaei Ave., Molasadra Ave., Vanak square Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
